• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性骨髓化生患者的脾切除术:对321例已发表病例的分析

Splenectomy in patients with agnogenic myeloid metaplasia: an analysis of 321 published cases.

作者信息

Benbassat J, Penchas S, Ligumski M

出版信息

Br J Haematol. 1979 Jun;42(2):207-14. doi: 10.1111/j.1365-2141.1979.tb01125.x.

DOI:10.1111/j.1365-2141.1979.tb01125.x
PMID:465366
Abstract

The available data on 321 published cases of splenectomy in agnogenic myeloid metaplasia were reviewed. Anaemia and thrombopenia were the most common indications for this operation. Patients reported after 1940 had a median postoperative survival of 13 months. Their postoperative mortality was 7.5% after 2 d and 25.7% after 3 months. The postoperative mortality was significantly higher when the weight of the spleen exceeded 2000 g, or in patients with platelet count less than 70 X 10(9)/l. The most common causes of death were infections (34.4%), cardiac or thromboembolic events (26.4%) and haemorrhage (17.6%). Leukaemic transformation was reported in 11.2% of the cases.

摘要

对321例已发表的原发性骨髓化生脾切除术病例的现有数据进行了回顾。贫血和血小板减少是该手术最常见的指征。1940年后报告的患者术后中位生存期为13个月。术后2天的死亡率为7.5%,3个月后为25.7%。当脾脏重量超过2000g或血小板计数低于70×10⁹/L时,术后死亡率显著更高。最常见的死亡原因是感染(34.4%)、心脏或血栓栓塞事件(26.4%)和出血(17.6%)。11.2%的病例报告有白血病转化。

相似文献

1
Splenectomy in patients with agnogenic myeloid metaplasia: an analysis of 321 published cases.原发性骨髓化生患者的脾切除术:对321例已发表病例的分析
Br J Haematol. 1979 Jun;42(2):207-14. doi: 10.1111/j.1365-2141.1979.tb01125.x.
2
'Early' splenectomy and survival in agnogenic myeloid metaplasia. An analysis of 338 cases published since 1940.原发性骨髓化生的“早期”脾切除术与生存率。对1940年以来发表的338例病例的分析
Acta Haematol. 1981;65(3):189-92. doi: 10.1159/000207177.
3
Experience with splenectomy in auto-immune thrombocytopenia and agnogenic myeloid metaplasia.自身免疫性血小板减少症和特发性骨髓化生的脾切除术经验。
S Afr Med J. 1976 Sep 11;50(39):1506-12.
4
Sex and splenectomy in agnogenic myeloid metaplasia.无病因性骨髓化生中的性别与脾切除术
Acta Haematol. 1980;64(2):114-6. doi: 10.1159/000207221.
5
Influence of splenectomy on hemostasis in agnogenic myeloid metaplasia.脾切除术对原发性骨髓化生止血功能的影响。
Haemostasis. 1987;17(3):141-6. doi: 10.1159/000215572.
6
Splenectomy in myeloid metaplasia.骨髓化生中的脾切除术。
Blood. 1979 Mar;53(3):515-8.
7
Effect of splenectomy on teardrop-shaped erythrocytes in agnogenic myeloid metaplasia.脾切除术对原发性骨髓化生中泪滴状红细胞的影响。
Arch Intern Med. 1977 Mar;137(3):380-1.
8
Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.原发性骨髓化生和真性红细胞增多症后骨髓化生中的脾切除术。34例研究。
Arch Intern Med. 1988 Nov;148(11):2501-5.
9
Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction.骨髓化生的骨髓纤维化患者的脾切除术:预处理变量与预后预测
Leukemia. 1993 Feb;7(2):200-6.
10
The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival.特发性骨髓纤维化综合征。一项侧重于预测生存的预后变量的临床病理综述。
Medicine (Baltimore). 1983 Nov;62(6):353-71.

引用本文的文献

1
How I treat splenomegaly in myelofibrosis.我如何治疗骨髓纤维化所致的脾肿大。
Blood Cancer J. 2011 Oct;1(10):e37. doi: 10.1038/bcj.2011.36. Epub 2011 Oct 7.
2
How should we manage myelofibrosis?我们应该如何治疗骨髓纤维化?
J R Coll Physicians Lond. 1981 Jan;15(1):17-8.
3
Splenectomy in agnogenic myeloid metaplasia: factors of possible prognostic significance.原发性骨髓化生行脾切除术:可能具有预后意义的因素
Postgrad Med J. 1982 Apr;58(678):212-5. doi: 10.1136/pgmj.58.678.212.
4
Bone biopsy in haematological disorders.血液系统疾病中的骨活检
J Clin Pathol. 1982 Mar;35(3):257-84. doi: 10.1136/jcp.35.3.257.
5
Splenectomy for hematologic disease. The UCLA experience with 306 patients.血液系统疾病的脾切除术。加州大学洛杉矶分校对306例患者的经验。
Ann Surg. 1984 Jul;200(1):40-5. doi: 10.1097/00000658-198407000-00006.
6
Elective splenectomy in haematological disorders.血液系统疾病中的择期脾切除术。
Ann R Coll Surg Engl. 1988 Jan;70(1):29-33.